NMN vs Nicotinamide Riboside
The two NAD+ precursors with head-to-head human data: a 2026 Nature Metabolism trial found both roughly doubled blood NAD+ over 14 days, and neither has shown a hard clinical outcome benefit.
Nicotinamide Mononucleotide
A direct NAD+ precursor studied for metabolic and physical-function benefits in aging, with early human trials and a contested regulatory status in the US.
Nicotinamide Riboside (NR)
A well-studied vitamin B3 form and NAD+ precursor that reliably raises NAD+ levels in humans, widely used in longevity supplement stacks.
| Attribute | NMN | Nicotinamide Riboside |
|---|---|---|
| Category | Longevity | Longevity |
| FDA status | Not an approved drug; US supplement status contested | Sold as a supplement; not an approved drug |
| Half-life | Short | Short |
| Molecular weight | 334.2 Da | 255.2 Da |
| Mechanism | Converts to NAD+ through the salvage pathway, aiming to restore NAD+ levels that decline with age. | Converts to NAD+ through the salvage pathway, restoring NAD+ that declines with age and supporting mitochondrial and repair enzymes. |
| Legal status (US) | Not approved; FDA excluded it from the supplement definition (2022) | Sold as a dietary supplement |
Frequently asked questions
What is the difference between NMN and Nicotinamide Riboside?
NMN: A direct NAD+ precursor studied for metabolic and physical-function benefits in aging, with early human trials and a contested regulatory status in the US. Nicotinamide Riboside: A well-studied vitamin B3 form and NAD+ precursor that reliably raises NAD+ levels in humans, widely used in longevity supplement stacks.
Which has stronger research evidence, NMN or Nicotinamide Riboside?
NMN is rated Preliminary and Nicotinamide Riboside is rated Moderate for evidence level in this database. Evidence level reflects the quality of published research, not a recommendation.
Are NMN and Nicotinamide Riboside FDA-approved?
NMN: Not an approved drug; US supplement status contested. Nicotinamide Riboside: Sold as a supplement; not an approved drug.
Evidence levels reflect the quality of published research, not a recommendation. This comparison is educational and is not medical advice.